Comparative study of SARS-CoV-2 antibody titers between male and female COVID-19 patients living in Kurdistan region of Iraq

• Published in: Gene reports 2021-12, Vol.25, p.101409-101409, Article 101409
• Main Authors: Ishaq, Sonia Elia, Abdulqadir, Shang Ziyad, khudhur, Zhikal Omar, Omar, Shwan Ali, Qadir, Mahdi Khaled, Awla, Harem khdir, Rasul, Mohammed Fatih, Bapir, Ahmed Abdulrazzaq, Zanichelli, Anna, Mansoor, Muhammad Khalid, Kaleem, Muhammad, Rizwan, Muhammad Arif, Smail, Shukur Wasman, Babaei, Esmaeil
• Format: Article
• Language: English
• Subjects: IgG; IgM; SARS-CoV-2; Sex differences
• ISSN: 2452-0144; 2452-0144
• DOI: 10.1016/j.genrep.2021.101409

Recently, there is increasing evidence that coronavirus disease 2019 (COVID-19) causes men to experience more serious symptoms and have a higher mortality rate than women, but the association between sex and immune response stays unknown till now, and weather patient’s prognosis associated with sex or not is another vague in COVID-19. In this study, the SARS-CoV-2-specific antibody titer test was performed for 727 patients who were a positive RT-PCR result for COVID-19 and we determined the difference in immune response in both genders. Patients were divided into two groups based on their genders, which were 383 males and 344 females. Plasma was collected from the patients after 17 days of diagnosis with COVID-19, and the concentrations of specific antibodies (IgG and IgM) was measured by multiparametric immunoassay system (VIDAS). Results demonstrated that there was no significant difference in both IgM and IgG production in male participants compared to women. Moreover, despite there was a weak significant positive association between age and IgM in male patients, while there was no significant correlation between IgG and age for the same gender. On the other hand, a slight positive correlation between IgM and IgG with age was observed in female participants. Finally, it concluded that there was no sex biases in patients with COVID-19 in Erbil, Iraq. So, these findings are crucial to treat and care male and female’s patients infected with COVID-19 at hospitals. •Comparative antibody titers (IgM and IgG) between male and female COVID-19 patients•No significant difference in IgM and IgG production in both sexes•Findings are crucial to treat and care in hospitals of COVID-19 patients.